ArticleThe journal of headache and pain2024

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Patricia Pozo-Rosich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.